Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) FCF Margin (2016 - 2025)

Historic FCF Margin for OptimizeRx (OPRX) over the last 17 years, with Q3 2025 value amounting to 12.28%.

  • OptimizeRx's FCF Margin rose 42300.0% to 12.28% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.62%, marking a year-over-year increase of 117800.0%. This contributed to the annual value of 4.94% for FY2024, which is 161600.0% up from last year.
  • OptimizeRx's FCF Margin amounted to 12.28% in Q3 2025, which was up 42300.0% from 15.51% recorded in Q2 2025.
  • In the past 5 years, OptimizeRx's FCF Margin ranged from a high of 29.61% in Q1 2022 and a low of 19.32% during Q4 2023
  • Over the past 5 years, OptimizeRx's median FCF Margin value was 3.94% (recorded in 2024), while the average stood at 5.63%.
  • Its FCF Margin has fluctuated over the past 5 years, first soared by 641600bps in 2021, then crashed by -330800bps in 2023.
  • OptimizeRx's FCF Margin (Quarter) stood at 8.05% in 2021, then surged by 271bps to 13.76% in 2022, then crashed by -240bps to 19.32% in 2023, then surged by 102bps to 0.29% in 2024, then soared by 4079bps to 12.28% in 2025.
  • Its FCF Margin stands at 12.28% for Q3 2025, versus 15.51% for Q2 2025 and 17.36% for Q1 2025.